As of 2026-04-01, K药（帕博利珠单抗）'s data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 4.08%, above the industry average by 4.1 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Positive mention rate (4.08%) is slightly higher than negative (0.00%), continue monitoring public sentiment. Among 6 competitors in the same category, K药（帕博利珠单抗）'s overall mention rate surpasses 6 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
K药（帕博利珠单抗）'s Mention Rate is 4.08%, lower than 0.6% of competitors
K药（帕博利珠单抗）'s First Mention is 0.00%, lower than 0.9% of competitors
K药（帕博利珠单抗）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
K药（帕博利珠单抗）'s Positive Rate is 4.08%, lower than 8.9% of competitors
K药（帕博利珠单抗）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| KK药（帕博利珠单抗） (Current Brand) | 4.08% | 0% | 0% | 4.08% | 0% | View Details |
| EEnhertu | 0% | 0% | 0% | 0% | 0% | View Details |
| SSkyrizi（利生奇珠单抗） | 0% | 0% | 0% | 0% | 0% | View Details |
| 达达雷妥尤单抗 | 0% | 0% | 0% | 0% | 0% | View Details |
| 英英飞凡 | 0% | 0% | 0% | 0% | 0% | View Details |
| 奥奥希替尼 | 0% | 0% | 0% | 0% | 0% | View Details |
| 依依沃西单抗 | 0% | 0% | 0% | 0% | 0% | View Details |
